Testing a home device to help chronic heart failure
Part of Heart & circulation clinical trials.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- You have chronic heart failure and are in NYHA Class II, III, or IV
- You may qualify if you are NYHA Class III or IV, or Class II with kidney disease, recent heart-failure hospitalization, high NT-proBNP blood test, or COPD
- You must have enough home cellular coverage so the device can connect
- You cannot have severe COPD (GOLD stage III or IV)
- You must be able to use the device safely (mobility, memory, and a caregiver if needed), and your left chest/breast skin must be in good condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how a small monitor inside the blood vessel to the lungs helps manage heart failure. It aims to improve care for people with advanced heart failure.
This study tests a remote monitoring device that sends information to your care team to help adjust your heart failure medications. It aims to improve your condition after a hospital stay for heart failure.
This study tests a heart device (CCM) plus standard medications to see if the combination helps people with a weak heart pump. It's for those whose heart function is low and who still have symptoms despite current treatment.
This study is looking at how well the CardioMEMS heart monitor works for people with heart failure. The device is already implanted and tracks pressure in your lung artery to help your doctor manage your condition and potentially prevent hospital visits.
This trial tests whether a wearable home monitoring system (myCordella™) can help people with moderate heart failure (NYHA class II or III) by tracking heart pressure and supporting follow-up care. It may help detect changes earlier so clinicians can adjust treatment sooner.
This study checks how safe a small heart-pressure monitoring device is for people with advanced heart failure and severe kidney problems. It looks at whether doctors can continuously track heart filling/pressure to help manage symptoms and reduce risks.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.